The invention relates to methods for treating pruritus with an NK-1 receptor antagonist. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonist.
-
(2014/12/12)
POLYMORPHS OF A HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONIST
This application is directed to a novel polymorph of a hydroisoindoline tachykinin receptor antagonist having the following structural formula A.
-
Page/Page column 24-25
(2008/12/05)
Process for making hydroisoindoline tachykinin receptor antagonists
The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
-
Page/Page column 14; 15
(2008/06/13)
More Articles about upstream products of 920025-45-2
Get Best Price for920025-45-21-Propanesulfonic acid,
1,1'-[[(1S,2R,3R,4S)-4-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-
(4-fluorophenyl)-1,2-cyclohexanediyl]bis(methylene)] ester